reviewTop 10% cited
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
Leukemia · 2001 · Vol. 15(6) · pp. 875–890
Adenosine and Purinergic SignalingChronic Lymphocytic Leukemia ResearchHIV/AIDS drug development and treatmentNucleoside transporterNucleoside analogueCladribineNucleosideFludarabinePharmacologyIntracellularTransporterDrug resistanceGemcitabine
MeSH terms
GemcitabineAcute DiseaseAnimalsAntimetabolites, AntineoplasticArabinonucleosidesBiological TransportCarrier ProteinsCytarabineCytidine DeaminaseCytosineDeoxyadenosinesDeoxycytidineDeoxycytidine KinaseDioxolanesDNA-Directed DNA Polymerase
Funding
- Friedreich's Ataxia Research Alliance
- Alberta Cancer Foundation
- Ligue Contre le Cancer
- National Cancer Institute
Citations
490
FWCI
9.87
field-weighted impact
References
247
Percentile
99%
vs. same field & year
Citations per year
Cited by
The concentrative nucleoside transporter family, SLC28
Pflügers Archiv - European Journal of Physiology · 2004 · 419 citations
Mechanisms and insights into drug resistance in cancer
Frontiers in Pharmacology · 2013 · 653 citations
References
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Journal of Clinical Oncology · 1997 · 5,865 citations
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
Biochemical Journal · 1999 · 1,815 citations
Bcl-2 and the regulation of programmed cell death
The Journal of Cell Biology · 1994 · 2,332 citations
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
The Journal of Experimental Medicine · 1995 · 1,564 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.